Home / About Us / News and Resources / Insights Newsletter



Bundled Solutions

We have a bundled solution for your organization

Insights Enterprise Newsletter

Insights Newsletter: Put Cardiovascular Risks With Triptans in Perspective, Help Patients Navigate OTC Hearing Aids, and more!

Clinical pharmacy leadership updates including information on monkeypox, activated charcoal claims, the pharmacy technician shortage, and more!, and new CE for September, and more.

Insights Newsletter: Prepare for up to a Dozen Humira Biosimilars, Clear Up Confusion About Emergency Contraception, and more!

Clinical pharmacy leadership updates including information on monkeypox, activated charcoal claims, the pharmacy technician shortage, and more!, and new CE for September, and more.

Insights Newsletter: Prepare to answer questions about bivalent COVID-19 boosters, does psilocybin reduce heavy drinking, new abortifacient law changes, and more!

Clinical pharmacy leadership updates including information on monkeypox, activated charcoal claims, the pharmacy technician shortage, and more!, and new CE for September, and more.

Insights Newsletter: Educate About Monkeypox…and Limit Misinformation, Debunk Activated Charcoal Claims, Watch our Webinar About the Pharmacy Technician Shortage, and more!

Clinical pharmacy leadership updates including information on monkeypox, activated charcoal claims, the pharmacy technician shortage, and more!, and new CE for September, and more.

Insights Newsletter: Keep Adolescents on Track with Immunizations, Keto Diet Concerns on the Rise, How to Address Patients with Vaccine Hesitancy, and More!

Clinical pharmacy leadership updates including information on guidelines for Prevnar 20 and Vaxneuvance, cannabinoids and COVID-19, and new CE for March, and more.

Insights Newsletter: Help Reduce Barriers to Paxlovid for COVID-19, Learn About Beer, Wine, and Drug Interactions, July’s Webinars, and More!

Clinical pharmacy leadership updates including information on guidelines for Prevnar 20 and Vaxneuvance, cannabinoids and COVID-19, and new CE for March, and more.

Insights Newsletter: Overcome Barriers to Opioid Use for Cancer Pain, Avocados and Heart Health, New CE for June, and More!

Clinical pharmacy leadership updates including information on guidelines for Prevnar 20 and Vaxneuvance, cannabinoids and COVID-19, and new CE for March, and more.

Insights Newsletter: New Saffron Adulteration Concerns, Put New Heart Failure Guidelines in Perspective, New CE for May, and More!

Clinical pharmacy leadership updates including information on guidelines for Prevnar 20 and Vaxneuvance, cannabinoids and COVID-19, and new CE for March, and more.

Insights Newsletter: Calm the hype about new cannabinoids, get the latest on natural insect and tick repellents, new CE for April, and More!

Clinical pharmacy leadership updates including information on guidelines for Prevnar 20 and Vaxneuvance, cannabinoids and COVID-19, and new CE for March, and more.

Insights Newsletter: Clarify New Guidelines for Prevnar 20 and Vaxneuvance, Cannabinoids Getting COVID-19 Attention, and New CE for March, and More!

Clinical pharmacy leadership updates including information on guidelines for Prevnar 20 and Vaxneuvance, cannabinoids and COVID-19, and new CE for March, and more.